Latest news with #Label
Mint
5 days ago
- Entertainment
- Mint
Lounge Loves: ‘Asterix and Obelix', a foldover pizza sandwich and more
Earlier in March, I carried my entire Asterix and Obelix collection from my parents' home in Bengal to Mumbai. I wanted to introduce the popular French comic series to my seven-year-old son, who surprisingly got hooked in no time. So you can imagine our excitement when Netflix released the comic adaptation of Asterix and Obelix recently. We binge-watched all five episodes of the The Big Fight series, that go back in time to the beloved Gaulish warrior duo's childhood, including an incident where Obelix accidentally falls into a vat of magic potion and acquires superhuman strength. What got us most excited are some new characters like Apothika, an old friend of the village druid Getafix, and Metadata, the cool rebel girl, who helps Julius Caesar strategise the big fight between the Gauls and the Romans. This one's an absolute riot of fun. Like most boys his age, eight-and-a-half-year-old Palash Ranjan Sen, aka Poltu, loves reading Phantom comics. But unlike his peers, he has a scientist mother who is headed for an Arctic mission, and an uncle with an odd job—rehoming ghosts ousted by the forces of climate change and urbanisation. Sudeshna Shome Ghosh's delightful middle-grade novel takes you on a night-long taxi ride through the spookiest neighbourhoods of Kolkata. With fun illustrations by Pankaj Saikia, the story will not only resonate with readers around Poltu's age, but also their seniors. Weren't we all eight once, looking for friendly ghosts to spice up our boring lives swamped with school and holiday homework? I have a WhatsApp group with two friends—each of us in our 30s, navigating very different life stages—united by a love for home improvement finds. I call it calming capitalism. We trade notes on bedsheets, diffusers, label makers, and most recently, sunscreen for the group's only man, who's new to skincare. When I needed a spray bottle that could handle both my plant babies and my unruly curls, I turned to the youngest in the group, our resident make-up artist. She suggested Inovera (Label)'s mist spray bottle, and it's been a quiet joy. My leaves are perked up, and taming my hair feels like less of a chore now. The group chat? Still going strong, fuelled by product recs, tiny upgrades, and the everyday thrill of making life feel a little nicer. Hipsters everywhere will hate me for saying this: I hate sourdough. Don't mess with sandwich bread, I say. So it was with great suspicion that I tried a 'foldover pizza sandwich' at Breakaway Pizzeria and Café in Panaji last month, and—you know where this is going—I loved it. It's a take on the panuzzo, and has roots in Naples, like the Neapolitan pizza they serve. Breakaway's dough is 70% hydrated, which means there's 700 grams of water for every 1,000g of flour, and fermented for 44 hours. The bread is pulled by hand and baked fresh for every sandwich, which gives every panuzzo that perfectly mild char and the light little pockets that make Neapolitan pizza special. There's the comfort of bread, without it overwhelming the filling itself, whether it's fresh tomatoes and stracciatella with basil pesto, or meatballs with mozzarella.
Daily Mirror
23-05-2025
- Lifestyle
- Daily Mirror
Oodie slashes 73% off 'unbelievably soft' outdoor jackets
'Sometimes, all you need for a quick walk is comfort, and this outdoor Oodie offered just that, whilst keeping me dry in the process' While the warmer weather has finally arrived, British summers and bank holidays are famously unpredictable. It's the perfect reminder that while the season calls for picnics in the park, it's also a smart time to stock up on cosy essentials for those inevitable chilly spells. There's not far to look, because The Oodie's latest sale is making that simple. The popular loungewear brand has just launched a huge clearance event, cutting the price of its outdoor jackets by 73%. Previously priced at £109, these ultra-comfy jackets are now £29 each, a saving of £80. The offer is available from now until 2am on May 27/ For those yet to discover it, the outdoor Oodie takes the brand's viral oversized fleece hoodie and transforms it into a practical, all-weather jacket. It features the same snuggly fleece lining on the inside that has become iconic for instant warmth. Alternatively, check out this Green Label Women's Appin Gilet from Hunter for £85. The insulated gilet features a quilted design and practical pockets to keep you warm on chillier days. Frasers is also having a huge sale and there's half price off this Barbour Zola Quilted Jacket, now £85 down from £169. Available in a selection of colours and styles while stocks last, it's an ideal layering piece for any wardrobe. Plus, it also boasts a water-repellent nylon outer layer to fend off sudden showers, ideal with another bank holiday downpour expected. The outdoor Oodie's have become a go-to favourite for anyone who loves the outdoors or staying snug in unpredictable weather. Fans have praised the jacket for keeping them 'completely dry', even when caught out in unexpected rain, making it a reliable option for everything from the morning dog walks, school runs and evening strolls. Alongside its cosy feel and waterproof finish, each outdoor jacket generously sized hood, ribbed cuffs and roomy side pockets for storing essentials. In reviews for the Camel/Black Zip Through Outdoor Jacket shoppers praised the comfort and stylish finish of the jacket. Our colleague at Liverpool Echo tried the Outdoor Oodie out for herself, and has written all about exactly why she has fallen in love with the product. She said: "I slipped into this Oodie, I couldn't believe how unbelievably soft it was inside. It was warm, but not absolutely boiling, and basically felt like I was wearing a giant duvet. "Sometimes, all you need for a quick walk is comfort, and this outdoor Oodie offered just that, whilst keeping me dry in the process. I was a little unsure that the Oodie might look a bit ridiculous in public, but despite it being big, it just looked like an oversized coat. "If you want to be really outlandish, you could wear the coat with the fleece side on show, but I didn't feel quite confident to wear the greyhound zip through print in public just yet! The hood was really roomy, and the pockets were ideal for snacks and all my belongings. "I'd definitely recommend checking out the outdoor Oodie if you're a dog walker like me. It was so soft and comfortable, and great to just throw on." It is worth noting, some customers found the jackets had creases that made them less easy to wear. One comment said: "The creases make it unwearable; it needs a steam iron." But another happier shopper said: "I got this coat on a whim, and honestly, best decision ever! It's so warm, and because I got the oodie size, I don't feel tight or restricted. It's so warm, I feel so comfortable in it, and its quality is amazing!"
Yahoo
09-04-2025
- Health
- Yahoo
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025
OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025New Clinical Data from Phase 2 Extension Period in Ulcerative Colitis on Long-Term Benefits and Safety of Anti-IL-7R mAb Lusvertikimab NANTES, France – April 9, 2025, 7:30 a.m. CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno-inflammation, today announced that the Company will present further efficacy and safety data1 from the 24-week Open Label Extension (OLE) period from CoTikiS Phase 2 clinical study of Lusvertikimab in ulcerative colitis at the Digestive Disease Week conference in San Diego (May 3 – 6, 2025). Following the excellent efficacy and safety profile from the trial's induction period presented as a highlight at the 2025 ECCO congress, this oral presentation will unveil new clinical data from the 24-week Open Label Extension (OLE) period (Week 10 to Week 34) of the randomized, double-blind, placebo-controlled Phase 2 study evaluating the anti-IL-7 receptor monoclonal antibody Lusvertikimab in moderate to severe ulcerative colitis. These new findings are expected to provide deeper insights into the long-term benefits and safety of Lusvertikimab, supporting further development in ulcerative colitis, as well as in other chronic autoimmune and inflammatory diseases. Presentation details: Title: 'LUSVERTIKIMAB, A FIRST IN CLASS IL7 RECEPTOR ANTAGONIST, IN MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A MULTICCENTER RANDOMIZED PLACEBO-CONTROLLED PHASE II STUDY' Date and Time: Monday, May 05, 2025, from 4:45pm to 5:00pm Pacific TimeSession Presentation: Clinical Trials in IBD: Biologics and Emerging TherapiesSession Number: 0004 ABOUT ULCERATIVE COLITIS (UC)Ulcerative colitis is a chronic disease of the large intestine, or colon, and rectum, in which the lining of the gastrointestinal tract becomes inflamed and develops ulcers. This condition is the result of an overactive immune system. UC affects 3.3 million patients in the US, Europe and Japan2. Despite broad therapeutic options, remission rates are only 25-30%3 leaving most patients without satisfactory treatments. 15% of patients4 fail to respond to all therapies and undergo surgery as a last option. ABOUT OSE IMMUNOTHERAPEUTICS OSE Immunotherapeutics is a biotech company dedicated to developing first-in-class assets in immuno-oncology (IO) and immuno-inflammation (I&I) that address the unmet patient needs of today and tomorrow. We partner with leading academic institutions and biopharmaceutical companies in our efforts to develop and bring to the market transformative medicines for people with serious diseases. OSE Immunotherapeutics is based between Nantes and Paris and is quoted on Euronext. Additional information about OSE Immunotherapeutics assets is available on the Company's website: Follow us on Fiona Dé French Media Contact FP2COMFlorence Portejoiefportejoie@ 6 07 768 283U.S. Media ContactRooney Partners LLCKate Barrettekbarrette@ 212 223 0561 Forward-looking statementsThis press release contains express or implied information and statements that might be deemed forward-looking information and statements in respect of OSE Immunotherapeutics. They do not constitute historical facts. These information and statements include financial projections that are based upon certain assumptions and assessments made by OSE Immunotherapeutics' management considering its experience and its perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements include statements typically using conditional and containing verbs such as 'expect', 'anticipate', 'believe', 'target', 'plan', or 'estimate', their declensions and conjugations and words of similar import. Although the OSE Immunotherapeutics management believes that the forward-looking statements and information are reasonable, the OSE Immunotherapeutics' shareholders and other investors are cautioned that the completion of such expectations is by nature subject to various risks, known or not, and uncertainties which are difficult to predict and generally beyond the control of OSE Immunotherapeutics. These risks could cause actual results and developments to differ materially from those expressed in or implied or projected by the forward-looking statements. These risks include those discussed or identified in the public filings made by OSE Immunotherapeutics with the AMF. Such forward-looking statements are not guarantees of future performance. This press release includes only summary information and should be read with the OSE Immunotherapeutics Universal Registration Document filed with the AMF on April 30, 2024, including the annual financial report for the fiscal year 2023, available on the OSE Immunotherapeutics' website. Other than as required by applicable law, OSE Immunotherapeutics issues this press release at the date hereof and does not undertake any obligation to update or revise the forward-looking information or statements. 1 The abstract was submitted before the completion of the 24-week Open Label Extension (OLE) period. The new data to be presented at DDW 2025 includes additional findings not available at the time of submission.2 Evaluate Pharma3 Drugs Context. 2019; 8: 212572 –doi: 10.7573/dic.2125724 Scientific Reports volume 10, Article number: 12546 (2020) Attachment EN_250409_DDW_Lusvertikimab_vf
Khaleej Times
27-01-2025
- Business
- Khaleej Times
Travel Revolution: Solartrip Brings AI and Blockchain to the Middle East
Travel is evolving from simple trips to meaningful journeys that emphasise personal growth, connection, and unforgettable experiences. Today's travellers no longer settle for standard itineraries — they seek adventures tailored to their unique interests. Solartrip has entered the Middle East market with a bold new vision for travel, combining AI-driven personalisation with blockchain-powered rewards. Focused on delivering seamless and secure experiences, Solartrip aims to redefine how people and businesses engage with travel in the region. Innovation at the Core: AI, Blockchain At Solartrip, innovation isn't just a buzzword — it's the foundation of a new way to experience travel. By integrating cutting-edge AI and blockchain technologies, Solartrip ensures every journey is secure, personalised, and effortless. Central to this transformation is Solly, Solartrip's AI-powered travel assistant. With 76 per cent of consumers preferring personalized services, Solly elevates the travel experience by offering tailored, real-time suggestions. Need a quiet café to work from or last-minute dinner plans? Solly ensures each trip feels uniquely yours, adapting to your preferences every step of the way. Meanwhile, blockchain is reshaping the financial side of travel. Supporting over 300 cryptocurrencies, Solartrip offers seamless, borderless payments — a feature especially appealing to forward-thinking markets like the UAE. The company's NFT-based rewards system takes loyalty programmes to the next level, allowing users to earn and trade digital collectibles, turning rewards into something tangible and valuable. From Solly's curated recommendations to competitive hotel prices, Solartrip's platform is built for flexibility and customization. Adding further value, the Solar Cash programme rewards users with five per cent bonuses on every stay booked via the website or app. These bonuses can be used to offset future bookings, offering travelers freedom to make today's journey pave the way for tomorrow's adventures. Solartrip streamlines every aspect of travel — from planning to payment to rewards — creating a more seamless and enriching experience for travellers. Empowering Businesses Through Travel-Tech The company's commitment to innovation extends beyond individual travellers to empower businesses through its advanced travel loyalty solution. By harnessing the same technologies that redefine personal travel, Solartrip's White Label enables banks, telecoms, airlines, payment systems, and even crypto exchanges to seamlessly offer travel solutions to their customers. This fully customisable platform seamlessly integrates into a company's website or app, enabling customers to effortlessly book travel, earn and redeem loyalty points, receive cashback, or even pay in installments. With access to over two million accommodation options, more than 800 airlines, and a variety of low-cost carriers, businesses can offer their customers a wide range of travel choices. Whether it's cashback on bookings or bonus points for spending, businesses can tailor incentives to suit customer preferences and align with their business goals. Solartrip offers a white-label solution that businesses can easily personalize to match their identity. Companies can offer a premium travel service under their own brand and earn commissions on bookings. This approach allows businesses to monetize their customer base without dealing with technical integrations, negotiating with travel providers, or managing customer service. In just 2-4 months, businesses can launch a top tier travel offer that elevates customer loyalty, drive growth, and increase revenue. This solution taps into the fast-growing $1.57 billion loyalty market in the UAE, meeting the demand for personalized, experience-driven rewards. Solartrip's Vision of Neo Travel While its technology empowers businesses and individual travellers, Solartrip's vision extends further. By understanding the evolving needs of modern travelers, Solartrip is redefining global travel trends, offering personalised and meaningful experiences that resonate with today's explorers. The rise of bleisure travel, where more than half of business travelers extend their trips for leisure, reflects a growing desire to combine productivity with relaxation. Staycations, especially in urban hubs like the UAE, are also booming, with New Year's Eve hotel bookings increasing by 300 per cent. These local escapes allow travelers to rediscover their cities while enjoying affordable getaways. Meanwhile, solo travel and experiential tourism continue to gain momentum as people seek deeper connections and authentic adventures, from hidden destinations to immersive cultural experiences. These trends are reshaping travel. Looking ahead, Solartrip is poised to lead travel-tech innovation, focusing on the Mena region with Dubai as a strategic hub. Over the next 2-3 years, the company plans to expand by partnering with local fintechs, banks, and businesses to launch white-label solutions offering customised travel loyalty programs across the region. Dubai's role as a global innovation hub provides the perfect environment for Solartrip to grow. The city's tech-forward infrastructure and growing demand for personalised travel experiences make it an ideal base for the company. Solartrip's vision is to set new standards in travel loyalty and continue driving innovation in the Mena region and beyond. • •
